For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.

A test commonly used to confirm a condition linked to high blood pressure is often inaccurate, causing doctors to skip ...

Novo Nordisk lowered its full-year guidance as copycat versions of its blockbuster weight-loss and diabetes drugs in the U.S.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...